Evidence map›Paper›PMID 24420499›Full record

Trial reportIntensive care medicine2014

Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial.

Pierre Kalfon, Bruno Giraudeau, Carole Ichai, Alexandre Guerrini, Nicolas Brechot, Raphaël Cinotti, Pierre-François Dequin, Béatrice Riu-Poulenc, Philippe Montravers, Djilalli Annane and 4 more

Registry-linked trialOpen access · bronzeAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02634411 (Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia), which is not on this map. Cited by 61 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 9 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02634411 nacompletednot on this mapstarted 2016, after this paper: background citation

Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia : a Randomized Controlled Study (iDIAPASON)

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2016 to 2018Enrolled190ConditionsVentilator-Associated PneumoniaArms8 days of effective antibiotic treatment, 15 days of effective antibiotic treatment
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 9 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. [S3 Guideline Sepsis-prevention, diagnosis, therapy, and aftercare : Long version].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2020
    Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Guideline
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Review
  17. Article
  18. Sepsis as CNS-governed metabolic triage.Frontiers in immunology · 2026
    Review
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 13 institutions in 1 country.

Pierre KalfonService de Réanimation polyvalente, Hôpital Louis Pasteur, Hôpitaux de Chartres, Chartres Cedex, 28018, Le Coudray, France. pkalfon@ch-chartres.fr.
Bruno GiraudeauINSERM CIC (Centre d'investigation clinique) 202, Centre Hospitalier Universitaire (CHU) de Tours, Tours, France.
Carole IchaiService de Réanimation médico-chirurgicale, Hôpital Saint-Roch, CHU de Nice, Nice, France.
Alexandre GuerriniLK2, Saint-Avertin, France.
Nicolas BrechotService de Réanimation médicale, Institut de Cardiologie, CHU Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Raphaël CinottiService de Réanimation chirurgicale cardio-thoracique et vasculaire, Hôpital Laennec, CHU de Nantes, Nantes, France.
Pierre-François DequinService de Réanimation médicale, Hôpital Bretonneau, CHRU de Tours, Tours, France.
Béatrice Riu-PoulencService de Réanimation polyvalente, Hôpital Purpan, CHU de Toulouse, Toulouse, France.
Philippe MontraversDépartement d'Anesthésie et Réanimation chirurgicale, CHU Bichat-Claude Bernard, AP-HP, Paris, France.
Djilalli AnnaneService de Réanimation, CHU Raymond Poincaré, AP-HP, Garches, France.
Hervé DupontService d'Anesthésie Réanimation, Hôpital Nord, CHRU Amiens, Amiens, France.
Michel SorineInstitut National de Recherche en Informatique et en Automatique (INRIA), Rocquencourt, France.
Bruno RiouUMR INSERM 956, Université Pierre et Marie Curie, Paris, France.
CGAO–REA Study Group
Assistance Publique – Hôpitaux de Paris · FRBretonneau Hospital · FRCentre de Recherche en Informatique · FRHôpital Laennec · FRHôpital Nord · FRHôpital Purpan · FRHôpital Raymond-Poincaré · FRHôpital Saint Roch · FRInserm · FRInstitut national de recherche en informatique et en automatique · FRLes Hôpitaux de Chartres · FRSorbonne Université · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe blood glucose target range and optimal method to reach this range remain a matter of debate in the intensive care unit (ICU). A computer decision support system (CDSS) might improve the outcome of ICU patients through facilitation of a tighter blood glucose control.

methodsWe conducted a multi-center randomized trial in 34 French ICU. Adult patients expected to require treatment in the ICU for at least 3 days were randomly assigned without blinding to undergo tight computerized glucose control with the CDSS (TGC) or conventional glucose control (CGC), with blood glucose targets of 4.4-6.1 and <10.0 mmol/L, respectively. The primary outcome was all-cause death within 90 days after ICU admission.

resultsOf the 2,684 patients who underwent randomization to the TGC and CGC treatment groups, primary outcome was available for 1,335 and 1,311 patients, respectively. The baseline characteristics of these treatment groups were similar in terms of age (61 ± 16 years), SAPS II (51 ± 19), percentage of surgical admissions (40.0%) and proportion of diabetic patients (20.3%). A total of 431 (32.3%) patients in the TGC group and 447 (34.1%) in the CGC group had died by day 90 (odds ratio for death in the TGC 0.92; 95% confidence interval 0.78-1.78; p = 0.32). Severe hypoglycemia (<2.2 mmol/L) occurred in 174 of 1,317 patients (13.2%) in the TGC group and 79 of 1,284 patients (6.2%) in the CGC group (p < 0.001).

conclusionsTight computerized glucose control with the CDSS did not significantly change 90-day mortality and was associated with more frequent severe hypoglycemia episodes in comparison with conventional glucose control.

Indexed as

Drug Therapy, Computer-AssistedBlood GlucoseCritical CareFemaleHumansHypoglycemic AgentsInsulinIntensive Care UnitsMaleMiddle AgedBlood GlucoseHypoglycemic AgentsInsulin

Identifiers

PMID24420499
OpenAlexW2036659903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.